Patterns of radiological progression in participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D) + bevacizumab (B) + transarterial chemoembolization (TACE) and placebos + TACE: EMERALD-1 post hoc analysis Meeting Abstract
| Authors: | Sangro, B.; Bouattour, M.; Park, J. W.; Diaz, C.; Erinjeri, J. P.; Alves, G. V.; Gu, S. Z.; Manikhas, A.; Kuroda, H.; Suksombooncharoen, T.; Vo, T. H. T.; Ostwal, V. S.; Eastgate, M. A.; Vaccaro, G. M.; Griffin, R.; Ali, S.; Balaji, K.; Chan, S. L. |
| Abstract Title: | Patterns of radiological progression in participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D) + bevacizumab (B) + transarterial chemoembolization (TACE) and placebos + TACE: EMERALD-1 post hoc analysis |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2025 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-01 |
| DOI: | 10.1200/JCO.2025.43.4_suppl.574 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| DOI/URL: | |
| Notes: | Meeting Abstract: 574 -- Source: CINAHL Plus with Full Text |
